View of THYROID STIMULATING HORMONE EVALUATION BETWEEN THREE AND FOUR WEEKS OF LEVOTHYROXINE WITHDRAWAL IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA

Return to Issue Details THYROID STIMULATING HORMONE EVALUATION BETWEEN THREE AND FOUR WEEKS OF LEVOTHYROXINE WITHDRAWAL IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA Download Download PDF